News
Levelle Nutrition Co-founder and CEO Linda Alvarez discusses the timely launch of Cycle Syncing Protein and its broader ...
Alpha1H shows benefit in non-muscle invasive bladder cancer, shrinking tumors and boosting the immune system with manageable ...
TipRanks on MSN20h
Bayer’s New Clinical Study on HER2-Targeted Cancer Treatment: A Potential Game Changer
Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG has launched a Phase 2 clinical ...
Zacks Investment Research on MSN22h
AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth
AbbVie ABBV holds a dominant position in the immunology market, which is being aided by strong sales of its two new ...
GlobalData on MSN19h
Animal testing alternatives to dominate, but not overnight
As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of ...
USD is seeking more than $293.5 million in funding for various projects over the years to come, for everything from ...
In response to a proposal submitted by Ravenbhel Healthcare of the fixed dose combination (FDC) pulmonary drug Bilastine 10 ...
First-time disclosures session at ACS Fall 2025 reveals diverse candidates for treating sickle cell disease, heart failure, ...
Chronic diseases, such as diabetes, cardiovascular conditions, autoimmune disorders, and cancer, represent an escalating global health challenge, exerting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback